Trials / Unknown
UnknownNCT03177746
The Safety of Dapoxetine/Tadalafil Combination Therapy
The Safety of Dapoxetine/Tadalafil Combination Therapy in Treatment of Men With Premature Ejaculation and Erectile Dysfunction
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Neutec Ar-Ge San ve Tic A.Ş · Industry
- Sex
- Male
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Dapoxetine/Tadalafil 30/20 mg film-coated tablet in the treatment of men with premature ejaculation and erectile dysfunction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dapoxetine/Tadalafil 30/20 mg film coated tablet | During 4-weeks treatment period, patients will take one Dapoxetine/Tadalafil 30/20 mg film coated tablet 1-3 hours before sexual intercourse. Study drug should not be used more than 1 tablet every 24 hours during the treatment. |
Timeline
- Start date
- 2022-12-31
- Primary completion
- 2023-01-14
- Completion
- 2023-10-14
- First posted
- 2017-06-06
- Last updated
- 2022-05-17
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03177746. Inclusion in this directory is not an endorsement.